Lupin's Goa facility may face regulatory action, says USFDA

The USFDA has stated that it may withhold approval of any pending
applications or supplements in which this facility is listed," it
added.

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/lupins-goa-facility-may-face-regulatory-action-says-usfda/articleshow/69586425.cms

Comments

Popular posts from this blog

Clinical Data Manager Job Opening @ Novartis- Apply Now

Stem Cell Facility Project Recruitment at AIIMS, New Delhi